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1. INTRODUCTION 
The accurate determination of mycotoxins in food and feed matrices for which EU 
legislative limits apply require robust and reliable analytical techniques.  The 
robustness and reliability are best shown through validation by a collaborative 
study. 
  Previous collaborative studies dealing with other mycotoxins [1-4] have shown 
that it is possible to achieve performance characteristics which are fit-for-purpose 
provided suitable methodology is available.  As with any interlaboratory 
comparison homogeneity between the test units is of utmost importance.  Due to the 
complexity of food and feed matrices particular care has to be taken during test 
material preparation to achieve this.  
  Methods for the determination of Fumonisin B1 (FB1) and Fumonisin B2 (FB2) 
have been subject to a collaborative study [5] in the past and the methodology used 
involved immunoaffinity clean-up to purify the sample extracts.  Detection was 
afforded by derivatisation of the Fumonisins to yield fluorescent derivatives before 
a chromatographic separation.  The reagent used was o-phtaldialdehyde and 
mercaptoethanol.   
  However, pre-column derivatisation does have disadvantages related to more 
demanding chromatography and the instability of the derivatives.  Strict time control 
of all processes is required to obtain adequate repeatability which necessitates the 
use of programmable auto liquid samplers (ALS).  This may be circumvented by 
using post column derivatisation instead. 
  Here the native Fumonisins are separated and reagents are added constantly to the 
effluent of the chromatographic column.  An additional pump, a mixing Tee, and 
additional tubing are needed for post column derivatisation replacing the need for a 
sophisticated ALS.  During method development it could be shown that both 
methods can perform equally well with respect to the requirements by EU 
legislation for method performance and working range [6]. 
  A collaborative study to validate a method for the “Determination of Fumonisin B1 
and B2 in Baby Food, Breakfast Cereals and Animal Feed by Immunoaffinity 
Column Clean-up with High Performance Liquid Chromatography and Fluorometric 
Detection” [7] failed partially because of problems with the immunoaffinity 
columns (IAC) used for the study.  After modifications to the method protocol 
regarding a check of proper performance of the IAC and the sample extract clean-up 
we describe below the results of a repeat of the study for compound animal feed and 
maize. 
2. METHOD OF ANALYSIS 
In brief, the method under investigation involved the following:  20 g of test 
material were extracted with 200 ml of 50 % methanol in phosphate-buffered saline 
for 2 h.  After settling of the particulate matter 5 ml of the supernatant were diluted 
to 50 ml with phosphate-buffered saline.  The diluted extract was filtered and 25 ml 
of it were applied to an immunoaffinity column.  Following a washing step with 10 
ml of phosphate-buffered saline the bound analytes were eluted with 5x500 µl 
methanol followed by 2 ml of water.  The eluate was collected and made up to 5 ml 
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with water.  This solution was then injected into a HPLC system.  After either pre- 
or post-column derivatisation with o-phtaldialdehyde and mercaptoethanol or N-
acetyl-cystein the derivatised analytes were quantified by fluorometry. 
  The detailed method protocol can be found in Annex C. 
3. LAYOUT OF THE COLLABORATIVE STUDY 
This collaborative study was planned according to guidelines of the AOAC Official 
Methods Program [8].  In particular, this means that five different materials would 
be measured as blind duplicates covering the concentration range of interest [9] as 
much as possible.  These five materials consisted of three individual materials 
(Levels B, C, SH) of which two (B, C) additionally had to be spiked by the 
participants out of two solutions of blinded concentration.  The spiked materials 
were to be used to determine recovery. 
  17 laboratories of 12 European Union Member States, all of them participants in 
the initial collaborative study [7], were invited to participate in this follow-up (see 
Annex A for details).  Each laboratory received: 
• Six test units identified by a code (blind duplicates of three materials) 
• Two test units identified as “Spike A”  
• Two test units identified as “Spike B”  
• One amber ampoule identified as “Spike solution A”  
• One amber ampoule identified as “Spike solution B”  
• One test unit identified as “Animal feed blank” (to be used in connection with 
one of the supplied IAC to optimise the LC separation conditions) 
• 14 immunoaffinity columns (IAC) 
• Vial with Fumonisin Mix reference material (if it was needed since the volume of 
the reference material provided for the previous study was insufficient)  
• Documentation: Method protocol, Spiking protocol, Cover letter, Copy of 
Certificate of Fumonisin Mix reference material (if it was requested), Results 
form, Questionnaire (all these documents can be found in Annex C). 
  The shipments to the participants were dispatched on 30 Sep 2009 and the deadline 
for reporting was set to 01 Dec 2009. 
4. PREPARATION OF TEST MATERIALS 
Various kinds of compound animal feed (rabbit, horse, pig feed) were purchased at 
local wholesalers.  After comminution of the materials with a Romer RAS® mill 
they were checked for the presence of FB1 and/or FB2 and found to be essentially 
free of the analytes (<140 µg/kg FB1, <60 µg/kg FB2). 
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  The comminuted and Fumonisin-free materials were mixed extensively (see Table 
1 Blank) in a rotating-drum mixer and then milled with a Retsch centrifugal mill 
(Model ZM 200) with a 3 mm sieve.  This process of mixing and milling was 
repeated twice with consecutively smaller sieves of 1 and 0.5 mm.  A comminuted, 
highly contaminated maize material was then blended with this homogenous blend 
of various Fumonisin-free compound animal feeds for the levels B and C or used 
pure for level SH.   
  The dilution of the highly contaminated maize material with the blank for Levels B 
and C was done according to the following scheme:  Equal amounts of 
contaminated and blank material were manually mixed and then milled (Model ZM 
200) with a 2 mm sieve.  The resulting contaminated material was then again mixed 
with an equal amount of blank material.  This was repeated until sufficient amounts 
of contaminated material at the desired contamination level were obtained.  Then 
the material was divided into 10 subsamples with a sample divider.  Each subsample 
was again divided into 10 new subsamples.  This was repeated twice.  All 
subsamples were then combined into two batches following a particular scheme.  
The two batches were combined and milled again (Model ZM 200) with a 1 mm 
sieve for the final homogenous material. 
Table 1: Composition of test materials 
Test Material Ingredient Parts Principal components 
Rabbit feed 4 cereals, seeds, crop by-products,  vegetables, minerals 
Horse feed 5 oat, barley flakes, flour pellets, corn flakes, pea flakes, fibres, oil, molasses Blank 
Pig feed 5 peas, roasted soy, wheat, barley, tapioca, cabbage  seeds, animal grease, corn, salt 
Blank 4 See "Blank" 
Level B 
Maize 1 Maize 
Blank 2 See "Blank" 
Level C 
Maize 1 Maize 
Level SH Maize 1 Maize 
 
5. STATISTICAL ANALYSIS 
To avoid the need to exclude laboratories with “outlying” results robust statistical 
methods were used for the estimation of repeatability and reproducibility as 
described in ISO 5725 Part 5 [10].  In particular, “Algorithm S” ([10], p. 36) was 
used to obtain a robust estimate of the standard deviation s* of the differences 
between the blind duplicates per material and “Algorithm A” ([10], p. 35) to obtain 
a robust estimate of the standard deviation sd of the averages of the blind duplicates 
per material. 
  The repeatability standard deviation sr can then be calculated as: 
2/∗= ssr  (1) 
The between-laboratory standard deviation sL is derived from sr and sd: 
)2/( 22 rdL sss −=  (2) 
If the expression under the square root is negative sL will become zero. 
Knowing sL and sr the reproducibility standard deviation sR is calculated as: 
22
rLR sss +=  (3) 
Relative standard deviations (RSD) were calculated as standard deviation times 100 
divided by the mean value: 
x
sRSD 100=  (4) 
Repeatability and reproducibility limits were calculated by multiplying the 
respective standard deviation with 2.8 which gives roughly a 95 % confidence at 
two replications: 
rr ssr 8.222 =∗∗=  (5) 
RR ssR 8.222 =∗∗=  (6) 
  Student’s t-test was used to determine significances of differences between means. 
6. IN-HOUSE METHOD PERFORMANCE AND VERIFICATION OF TEST MATERIAL 
HOMOGENEITY 
The method under investigation was validated as recommended ([8], Sec 1.3); in 
particular, useable calibration range, matrix interferences, recovery, 
chromatographic performance specifications, and precision were determined. 
  Since pre- or post-column derivatisation was permissible for this study we 
determined the useable calibration range for both.  With the instrumentation as 
described in the method protocol (see Annex C) a range from 10 ng/mL to 
2000 ng/ml of the individual Fumonisin in the injection solution was usable under 
both conditions.  Significant matrix interferences for different compound animal 
feeds or maize could not be detected (see chromatograms in Annex C) when 
observing the stated performance specifications for the HPLC, namely a peak 
asymmetry factor of 0.9< As <1.4 at 10% of full height, sufficient retention (k > 2), 
and resolution (Rs >1).  Apparent recovery was determined to be larger than 80% for 
both FB1 and FB2.  Relative repeatability standard deviations ranged from 7 % at ca. 
3000 µg/kg to 2 % at ca. 17000 µg/kg for the sum of FB1 and FB2.  Performance 
criteria laid down for food analysis Regulation (EC) No.401/2006 [6] were met by 
this method for feed analysis. 
7 
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  To verify homogeneity of the test materials 10 % of the total number of units per 
material were picked at random, e.g. 5 for Level B, 5 for Level C, and 10 for Level 
SH.  Two independent determinations were performed per unit with the method 
under investigation.  Sufficient homogeneity was assumed if the between-unit 
variance (s2sam) was not significantly different from the within-unit variance (s2an) 
with an α-error of 0.05. 
  The between-unit variance (s2sam) and the within-unit variance (s2an) were obtained 
from one-way analysis of variance (ANOVA).  The probability p of the two 
variances being identical was 0.98 for Level B, 0.34 for Level C, and 0.19 for Level 
SH.  Therefore sufficient homogeneity of all three test materials was assumed. 
7. RESULTS AND DISCUSSION 
Sixteen of the 17 participating laboratories reported back their measurement results 
for the ten test units they received.  One laboratory reported two sets of results.  One 
set was obtained following the method under investigation and the second set was 
obtained using LC-MS instead of HPLC-FLD.   
  The laboratories reported individual mass fractions for FB1 and FB2 (listed in 
Annex B).  For the purposes of this report we added the individual mass fractions to 
obtain the sum mass fraction of FB1 and FB2 and evaluated only this sum mass 
fraction (FBSUM).  Table 2 lists the calculated sums. 
Table 2: Sum mass fractions of FB1 plus FB2 in µg/kg for the blind duplicates of the five materials 
by laboratory. Spike A consists of Level C plus 3287 µg/kg FBSUM, Spike B of Level B plus 2740 
µg/kg FBSUM. Grey shading indicates exclusion because of non-compliance. 
Lab 
ID Spike A Spike B Level B Level C Level SH 
101 10103 9951 6099 5994 3546 3543 6222 6394 17680 16735
102 8976 8929 5677 5647 3038 3103 5721 5780 15191 15681
105 9571 9340 6140 6132 3426 3526 5044 6698 18576 18179
107 7207 6635 4772 4785 2706 2577 5099 4983 13785 14353
110 7646 7482 4734 4781 2874 2802 5257 4631 14660 14646
112 7888 7719 4767 4680 2716 2765 5118 4726 11791 12300
212 7350 7848 5113 4837 2942 2921 5266 5093 13540 13480
301 8375 9419 4813 4581 4622 4238 7462 9257 23808 20104
302 7874 7869 4853 4795 2868 2828 5482 5409 14960 14728
303 6595 5919 3547 3638 2125 2375 4636 4617 12960 12416
304 8583 8630 4668 4859 3381 3497 6030 5974 19106 19658
305 12267 11077 6149 5875 3886 3350 8210 5256 18524 18973
306 4352 4285 2503 2390 1177 1142 2802 2747 8442 8440
309 979 980 483 508 2503 2675 5153 6113 12033 12577
310 9290 9197 5811 5929 3707 3796 6650 6779 18277 18387
9 
Lab 
ID Spike A Spike B Level B Level C Level SH 
317 8162 7952 4538 4638 2841 2900 5494 5106 16694 16498
410 6828 6683 4141 4089 2480 2447 4584 4378 13578 13550
 
  Five sets of results had to be excluded from the evaluation because of non-
compliance (shaded grey in Table 2):  Laboratory 102 applied an additive to the 
mobile phase different from the one explicitly prescribed in the method protocol;  
Laboratory 305 used LC-MS because of failure of the HPLC-FLD system;  
Laboratory 306 did not meet the requirements for peak asymmetry (Method 
protocol clause 3.13.3) for the peaks of FB1 and FB2 in the calibration solutions 
indicating insufficient separation from reagent peaks which might be the cause of 
consistent underestimation of the mass fractions in the test materials;  Laboratory 
309 found unexplainable low mass fractions in the two spiked materials;  after 
contacting the laboratory inconsistencies with the calibration (response factors for 
FB2 several times larger than for FB1) were discovered which were in stark contrast 
to our experience; the additional set of results acquired with LC-MS (see above) is 
listed with Laboratory ID 410.  However, for informative purposes these results are 
depicted in the respective graphs. 
  Table 3 lists the performance parameters calculated from the reported values (no 
correction for individual recovery) as described in Sec. 5 above with exclusion of 
the non-compliant results. 
Table 3: Method performance parameters in ascending order of the mean; Spike B consists of Level 
B plus 2740 µg/kg FBSUM, Spike A of Level C plus 3287 µg/kg FBSUM; the apparent recoveries were 
calculated based on these additions; n.a. – not applicable. 
Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
Mean value x [μg/kg] 3110 5000 5600 8200 16000 
Repeatability standard 
deviation sr [μg/kg] 
Relative repeatability 
standard deviation RSDr 
[%] 
81.9 
 
2.6 
101 
 
2.0 
295 
 
5.3 
289 
 
3.5 
398 
 
2.5 
Repeatability limit r 
[μg/kg] 229 282 826 809 1120 
Reproducibility standard 
deviation sR [μg/kg] 
Relative reproducibility 
standard deviation RSDR 
[%] 
589 
 
19 
766 
 
15 
863 
 
15 
1230 
 
15 
3210 
 
20 
Horwitz ratio 1.4 1.2 1.3 1.3 1.9 
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Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
Reproducibility limit R 
[μg/kg] 1650 2140 2420 3450 8980 
Apparent recovery [%] n.a.  69 n.a. 79 n.a. 
 
  Based on the Horwitz ratios of 1.2 to 1.9 the performance of the investigated 
method is adequate.  The ratio of 1.9 for the highest level stands out even though 
RSDR is comparable to the other levels.  The reason is that the predicted RSDR 
according to the Horwitz equation is lowest for the highest mass fraction while the 
primary source of variation, namely the immunoaffinity clean-up step, is the same 
as for the lower levels.  There are no recommendations for performance of methods 
of feed analysis but performance criteria laid down for food analysis in Regulation 
(EC) No.401/2006 [6] are met by this method for feed analysis.  Only the apparent 
recovery in Spike B with 69 % is just outside the permissible range of 70 to 110 %. 
  To show how performance parameters would have changed if a classical approach 
of evaluation (outlier removal, parametric statistics) had been used Table 4 has been 
added. 
Table 4: Method performance parameters calculated with the classical approach in ascending order 
of the mean; Spike B consists of Level B plus 2740 µg/kg FBSUM, Spike A of Level C plus 3287 
µg/kg FBSUM; the apparent recoveries were calculated based on these additions; n.a. – not 
applicable. 
Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
Outliers removed 0 0 2 0 1 
Mean value x [μg/kg] 3150 4980 5450 8190 15600 
Repeatability standard 
deviation sr [μg/kg] 
Relative repeatability 
standard deviation RSDr 
[%] 
106 
 
3.4 
96.4 
 
1.9 
199 
 
3.7 
310 
 
3.8 
326 
 
2.1 
Repeatability limit r 
[μg/kg] 298 270 558 868 913 
Reproducibility standard 
deviation sR [μg/kg] 
Relative reproducibility 
standard deviation RSDR 
[%] 
600 
 
19 
720 
 
14 
691 
 
13 
1110 
 
14 
2510 
 
16 
Horwitz ratio 1.4 1.2 1.0 1.2 1.5 
Reproducibility limit R 1680 2020 1930 3120 7020 
11 
Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
[μg/kg] 
Apparent recovery [%] n.a.  67 n.a. 83 n.a. 
 
  It can be said that the classical evaluation approach leads to smaller estimates in 
most of the cases.  This comes at the cost of having to remove outliers which might 
invite discussions about whether the removal was justified.  Using robust statistics 
avoids this at some what more conservative estimates. 
  A helpful tool to analyze collaborative study data are graphical displays.  One way 
of displaying such data are so called Youden plots.  Youden plots are created when 
plotting the first result of a duplicate vs. the second for all laboratories.  They 
display in one glance repeatability (closeness of points to the identity line) and 
reproducibility (tightness of the cloud of points).   
  Mean & range plots are a second way of displaying the data.  Here the mean values 
and their ranges are plotted in ascending order for all laboratories.  Also depicted 
are the overall mean and the reproducibility limit for two replicates.  This kind of 
plot allows for quick identification of an individual laboratory's bias compared to 
the overall mean. Figure 1 to Figure 5 shows the two plots (top Youden, bottom 
Mean & Range) for the sum of the mass fractions of FB1 and FB2 for each of the 
five test materials.  The plots for the individual toxins can be found in Annex B. 
  Of the 16 laboratories which reported back results ten (three non-compliant) used 
pre-column derivatisation and five post-column.  One laboratory (non-compliant) 
used LC/MS for detection and one of the pre-column laboratories also reported 
results from LC/MS.  Looking at the graphs (Figure 1 to Figure 5) it can be seen that 
LC/MS delivers results comparable to HPLC-FLD.  
  It is also evident from the graphs that Laboratory 301 reported results which were 
the highest for all three naturally contaminated materials (Figures 1, 3, 5).  That is a 
highly unusual finding and suggests a bias not explainable by random variation.  
Looking at the graphs for the individual fumonisins it can be seen that the main 
driver behind this seems to be overestimation of FB2.  Furthermore, the differences 
between the spiked materials and the corresponding naturally contaminated 
materials were not significantly different from zero.  This suggests that the spiking 
was done improperly.  Upon questioning laboratory 301 replied that all procedures 
were done according to the protocol. 
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Figure 1, Level B, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass 
fraction determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass 
fraction determination by the organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the 
overall mean, the error bars the range of the blind duplicates; red colour indicates post-column derivatisation, 
black pre-column, and green LC-MS; non-compliant results are depicted by a “x”. 
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Figure 2, Spike B, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass 
fraction determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass 
fraction determination by the organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the 
overall mean, the error bars the range of the blind duplicates; red colour indicates post-column derivatisation, 
black pre-column, and green LC-MS; non-compliant results are depicted by a “x”. 
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Figure 3, Level C, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass 
fraction determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass 
fraction determination by the organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the 
overall mean, the error bars the range of the blind duplicates; red colour indicates post-column derivatisation, 
black pre-column, and green LC-MS; non-compliant results are depicted by a “x”. 
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Figure 4, Spike A, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass 
fraction determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass 
fraction determination by the organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the 
overall mean, the error bars the range of the blind duplicates; red colour indicates post-column derivatisation, 
black pre-column, and green LC-MS; non-compliant results are depicted by a “x”. 
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Figure 5, Level SH, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass 
fraction determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass 
fraction determination by the organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the 
overall mean, the error bars the range of the blind duplicates; red colour indicates post-column derivatisation, 
black pre-column, and green LC-MS; non-compliant results are depicted by a “x”. 
  Since robust methods were used to determine repeatability and reproducibility the 
results of laboratory 301 were not excluded from the evaluation.  However, the 
inclusion of these results is the main driver for a significantly higher mean of the 
post-column results compared to the pre-column results.  Without the influence of 
Laboratory 301 pre- and post-column derivatisation would not be different. 
  Something that stands out from all graphs is that the ratio of repeatability to 
reproducibility is much smaller than one would normally expect.  That causes the 
data to be so drawn-out in the Youden plots.  Since the homogeneity of the materials 
was demonstrated we believe that the immunoaffinity columns might be the cause.  
It appears that as long as one preparation of buffers and solvents is used within a 
limited time period within one laboratory precision is rather good.  But as soon as 
different environmental conditions, buffers, and operators are involved precision 
degrades quickly.  Any laboratory setting up uncertainty budgets for Fumonisin 
analyses should account for this properly. 
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  A questionnaire was filled-in by all of the 16 laboratories which reported results 
with questions about their experience, the adequacy of the method description, and, 
if any, deviations from the method protocol.   
  Every laboratory claimed previous experience with the determination of 
Fumonisins, in the majority of the cases it was more than 12 months (13 labs).  Two 
laboratories claimed an experience of 3 to 12 months and only one said they had 
less than three months of experience.  Whether the description of the method was 
adequate was answered with “Yes” by 13 laboratories.   
  Of the three laboratories which did not answer with “Yes” one remarked (i) that 
the  “batch of runs as described is too long” and that the need for a sufficient supply 
of pre-column derivatisation reagent was not mentioned.  The second laboratory 
remarked (ii) that the actual concentrations of the calibration solutions should be 
stated and the calibration range should be aimed at maximum recommended levels 
for feed.  Furthermore, it remarked that the reaction time for the post-column 
derivatisation set-up as described was very short.  The third laboratory remarked 
(iii) that the “freshness” of the pre-column derivatisation reagent was of importance 
and that the permissible age of the reagent was not stated. 
  Our reply is: (i) it is important from our experience to bracket samples between 
calibration samples and to run samples and calibration solutions at least in duplicate 
in changing order.  The reason is to account for drifts of the system and possible 
interactions between samples of widely differing concentrations.  For the purpose of 
this study this resulted in a long sequence.  It was up to the individual participant to 
make provisions for a sufficient supply of reagent since we are unable to make 
recommendations suitable for all the different instrumentations possibly used. 
  (ii) We did not state concentrations because FB1 & FB2 stock solutions of different 
concentrations were being used and that would have made for a very complex table.  
The calibration range was aimed at maximum recommended levels in feed since it 
covered the mass fraction range of 0.2 to 40 µg/kg for the individual Fumonisin and, 
hence, 0.4 to 80 µg/kg for the sum of FB1 & FB2.  And with regards to the shortness 
of the reaction time in the described post-column derivatisation set-up:  it had to be 
a compromise of sufficient reaction time and minimal band broadening due to extra-
column volumes and it worked well in our laboratory. 
  (iii) We agree and failed to mention in Sec. 4.19.2 of the method protocol that the 
pre-column reagent had to be prepared freshly for every batch of samples as it was 
mentioned for the post-column reagent. 
  A very important question was whether at any step of the protocol sections 4 
(“Reagents and Materials”), 5 (“Spiking procedure”), and 6 (“Sample preparation”) 
there were any deviations.  11 laboratories answered with “No” and five with “Yes”.  
Of the five laboratories which answered “Yes” (i) one did not perform the 
verification of a result above 10000 µg/kg by preparing and measuring an additional 
dilution of the raw extract (method protocol Sec. 6.1); (ii) one used disodium 
hydrogen phosphate dihydrate instead of disodium hydrogen phosphate 
dodecahydrate with properly adjusted weight (method protocol Sec. 4.6); (iii) one 
used volumetric flasks of volumes different from the ones described (method 
protocol Sec. 4.22) with properly adjusting the volumes of diluted stock solution; 
(iv) one used “back flushing” for the elution (method protocol Sec. 6.2) as described 
in the instructions of the immunoaffinity columns while maintaining all volumes; 
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(v) one filtered the extract before dilution (method protocol Sec. 6.1) instead of 
waiting for it to settle. 
  Deviations (ii), (iii), and (iv) were considered to be non-essential and therefore 
permissible.  Deviation (v) was performed by Laboratory 102 which also deviated 
from the prescribed mobile phase additive which led to its exclusion.  Deviation (i) 
was a disregard of the recommendation to verify results with mass fractions above 
10000 µg/kg which was made to safeguard against overloading of the 
immunoaffinity columns.  It did not lead to exclusion of the respective laboratory 
because the results of the affected material did not show an unusual bias as it would 
be expected if the capacity of the immunoaffinity column had been exceeded.   
  Fourteen of the laboratories reported a time range of 20 to 40 minutes for the 
immunoaffinity clean-up step, one laboratory reported less than 20 min, and one 
more than 40 min.   
  Whether deviations from the method protocol section 7 “Measurements” were 
made was also a question.  Surprisingly three laboratories answered this question 
with “No”. Since these three laboratories used equipment different from the one for 
which the recommendations were made it must be seen as incidental that the 
separation requirements as set out in the protocol (Sec 3.13.3) were met.  One of the 
remaining 13 laboratories changed the mobile phase additive which was a clear non-
compliance.  The other 12 laboratories introduced changes to the isocratic or 
gradient conditions and/or the autosampler settings in order to achieve acceptable 
separation as was recommended in the protocol.  
8. CONCLUSIONS 
It could be shown that the method under investigation performed satisfactorily.  
Evaluation of the reports of 16 laboratories from 12 Member States of the European 
Union resulted, after exclusion of 4 non-compliant laboratories, in relative 
reproducibility standard deviations of 15 % to 20% for contamination levels from 
3 mg/kg to 16 mg/kg for the sum of Fumonisin B1 and B2.  The Horwitz ratios of 1.2 
to 1.9 were all within the acceptable range and even performance criteria set out for 
food analysis [6] were met by this method of analysis for animal feed.   
  The compliant measurements were performed using pre-column derivatisation by 
seven laboratories and post-column derivatisation by five laboratories.  The 
performances of pre- and post-column derivatisation must be seen as comparable.  
The description of the method was judged as adequate by the majority of the 
laboratories. 
We consider this method as fit for the purpose of enforcing maximum recommended 
levels of the sum of Fumonisin B1 and B2 in animal compound feed and maize 
intended for animal feed [9] and have submitted it to the European Committee for 
Standardisation (CEN)/ Technical Committee (TC) 327 Animal feeding stuffs. 
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11. ANNEX A 
First Name Surname Company/Institute Address Postal 
Code 
Town Country (full) 
Dr. Benedikt Brand Staatliches Veterinäruntersuchungsamt 
Arnsberg 
Dezernat 43 - Verbraucherschutzprogramm, 
Futtermittel 
Zur Taubeneiche 10-12 D-59821 Arnsberg Germany 
Pedro A. Burdaspal Centro Nacional de Alimentación. Agencia 
Española de Seguridad Alimentaria 
Carretera de 
Majadahonda a Pozuelo, 
km2 
28220 Majadahonda Spain 
Petr Cuhra Czech Agriculture and Food Inspection Authority
NRL for mycotoxins 
Za Opravnou 6 150 06 Praha 5 Czech Republic 
Theo C. de Rijk RIKILT - Institute of Food Safety Bornsesteeg 45,  Gebouw 
123 
6708PD Wageningen The Netherlands 
Jozsef Dömsödi National Institute for Agricultural Quality Control Remeny u. 42 H-1144 Budapest Hungary 
Maria Elvira Esteves LCQA - Laboratorio Central de Qualidade 
Alimentar 
Av. Conde Valbom  98 1050.070 Lisboa Portugal 
Marie-Paule Herry Laboratoire du Ministère de l'Economie, des 
Finances et de l'Industrie (MINEFI) de Rennes 
26, rue Antoine Joly F-35000 Rennes France 
Dick Liefting MasterLab BV Nijverheidsweg 2 3881 LA Putten The Netherlands 
Jose Melo DIN  SA Catraia 3441-999 Santa Comba 
Dão 
Portugal 
Jaroslava Petrová ÚKZÚZ Praha Za Opravnou 4 150 06 Praha 5 Czech Republic 
Andreas Sczekalla Consumer Testing Services, 
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Yvonne Simonsen The Danish Plant Directorate Skovbrynet 20, Building A DK-2800 Lyngby Denmark 
Alexey Solyakov (SVA) The National Vetinary Institute 
Department of Animal Feed 
Travvägen 20 SE-75189 Uppsala Sweden 
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Jeroen Vancutsem Federaal Agentschap voor de Veiligheid van de 
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Yveta Vojsova State Veterinary and Food Institute Bratislava 
Department of Chemistry and Toxicology 
Botanicka 15 842 52 Bratislava Slovak Republic 
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12. ANNEX B 
The result tables and graphs for the individual fumonisins: 
Table B. 1: Mass fractions of FB1 in µg/kg for the blind duplicates of the five materials by laboratory. Spike A 
consists of Level C plus 2410 µg/kg FB1, Spike B of Level B plus 2009 µg/kg FB1. Grey shading indicates exclusion 
because of non-compliance. 
Lab 
ID Spike A Spike B Level B Level C Level SH 
101 8029 7950 4788 4710 2821 2818 5033 5181 14390 13584
102 7256 7218 4573 4550 2533 2590 4757 4807 12468 12843
105 7902 7693 4926 4908 2793 2841 4141 5507 15879 15546
107 6018 5528 3977 3977 2345 2238 4384 4274 11536 12017
110 6437 6281 3933 3979 2409 2339 4512 3945 12513 12522
112 6710 6548 4029 3967 2372 2403 4454 4346 10183 10564
212 6032 6497 4181 3965 2478 2462 4460 4284 11286 11237
301 6383 7251 3398 3370 3195 2826 5605 4647 16124 14877
302 6441 6421 3991 3944 2455 2441 4647 4595 12284 12096
303 5638 5034 3056 3121 1856 1985 4019 3942 11036 10584
304 6805 6841 3631 3773 2625 2724 4907 4794 14631 15055
305 9559 8812 4862 4665 3191 2734 6712 4343 15098 15626
306 3764 3750 2208 2092 1177 1142 2509 2513 7219 7265
309 542 528 163 165 2013 2176 4090 5054 9730 10246
310 7620 7529 4753 4823 3131 3197 5588 5705 15301 15245
317 6720 6396 3738 3894 2398 2402 4450 4294 13777 13564
410 5618 5507 3397 3367 2106 2068 3888 3703 11393 11345
 
Table B. 2: Method performance parameters for FB1 in ascending order of the mean; Spike B consists of Level B 
plus 2009 µg/kg FB1, Spike A of Level C plus 2410 µg/kg FB1; the apparent recoveries were calculated based on 
these additions; n.a. – not applicable. 
Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
Mean value x [μg/kg] 2490 3920 4590 6520 12700 
Repeatability standard 
deviation sr [μg/kg] 
Relative repeatability 
standard deviation RSDr 
[%] 
68.8 
 
2.8 
69.4 
 
1.8 
274 
 
6 
239 
 
3.7 
307 
 
2.4 
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Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
Repeatability limit r 
[μg/kg] 193 194 766 669 861 
Reproducibility standard 
deviation sR [μg/kg] 
Relative reproducibility 
standard deviation RSDR 
[%] 
432 
 
17 
789 
 
20 
630 
 
14 
1240 
 
19 
2410 
 
19 
Horwitz ratio 1.2 1.5 1.1 1.6 1.7 
Reproducibility limit R 
[μg/kg] 1210 2210 1760 3470 6750 
Apparent recovery [%] n.a.  71 n.a. 80 n.a. 
 
Table B. 3: Mass fractions of FB2 in µg/kg for the blind duplicates of the five materials by laboratory. Spike A 
consists of Level C plus 877 µg/kg FB2, Spike B of Level B plus 731 µg/kg FB2. Grey shading indicates exclusion 
because of non-compliance. 
Lab 
ID Spike A Spike B Level B Level C Level SH 
101 2074 2001 1311 1284 725 725 1189 1213 3290 3151
102 1720 1711 1104 1097 505 513 964 973 2723 2838
105 1669 1647 1214 1224 633 685 903 1191 2697 2633
107 1189 1107 795 808 361 339 715 709 2249 2336
110 1209 1201 801 802 465 463 745 686 2147 2124
112 1178 1171 738 713 344 362 664 380 1608 1736
212 1318 1351 932 872 464 459 806 809 2254 2243
301 1992 2168 1415 1211 1427 1412 1857 4610 7684 5227
302 1433 1448 862 851 413 387 835 814 2676 2632
303 957 885 491 517 269 390 617 675 1924 1832
304 1778 1789 1037 1086 756 773 1123 1180 4475 4603
305 2708 2265 1287 1210 695 616 1498 913 3426 3347
306 588 535 295 298 0 0 293 234 1223 1175
309 437 452 320 343 490 499 1063 1059 2303 2331
310 1670 1668 1058 1106 576 599 1062 1074 3086 3032
317 1442 1556 800 744 443 498 1044 812 2917 2934
410 1210 1176 744 722 374 379 696 675 2185 2205
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Table B. 4: Method performance parameters for FB2 in ascending order of the mean; Spike B consists of Level B 
plus 731 µg/kg FB2, Spike A of Level C plus 877 µg/kg FB2; the apparent recoveries were calculated based on these 
additions; n.a. – not applicable. 
Performance 
parameter 
Level B Spike B Level C Spike A Level SH 
Mean value x [μg/kg] 507 893 903 1430 2610 
Repeatability standard 
deviation sr [μg/kg] 
Relative repeatability 
standard deviation RSDr 
[%] 
20.3 
 
4 
29.3 
 
3.3 
102 
 
11 
44.3 
 
3.1 
66.5 
 
2.5 
Repeatability limit r 
[μg/kg] 56.9 82 286 124 186 
Reproducibility standard 
deviation sR [μg/kg] 
Relative reproducibility 
standard deviation RSDR 
[%] 
188 
 
37 
340 
 
38 
298 
 
33 
535 
 
37 
779 
 
30 
Horwitz ratio 2.1 2.3 2.0 2.5 2.1 
Reproducibility limit R 
[μg/kg] 526 952 835 1500 2180 
Apparent recovery [%] n.a.  53 n.a. 60 n.a. 
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Figure B. 1, Level B FB1, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 2, Level B FB2, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 3, Spike B FB1, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 4, Spike B FB2, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 5, Level C FB1, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 6, Level C FB2, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 7, Spike A FB1, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 8, Spike A FB2, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 9, Level SH FB1, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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Figure B. 10, Level SH FB2, Top: Youden plot; the solid line depicts the identity line and the broken lines the mass fraction 
determined by the organizing laboratory; the shaded area is the expanded uncertainty of the mass fraction determination by the 
organizing laboratory; Bottom: Mean & Range plot; the solid line depicts the overall mean, the error bars the range of the blind 
duplicates; red colour indicates post-column derivatisation, black pre-column, and green LC-MS; non-compliant results are 
depicted by a “x”. 
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13. ANNEX C 
Method protocol: 
 
EUROPEAN COMMISSION 
JOINT RESEARCH CENTRE 
 
Institute for Reference Materials and Measurements  
Food safety and quality 
 
 
 
Determination of the Sum of Fumonisin B1 & B2 in compound 
animal feed with immunoaffinity clean-up and RP-HPLC with 
fluorescence detection after pre-column derivatisation (optional 
post-column derivatisation) 
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Foreword 
READ THIS PROTOCOL CLOSELY! THERE HAVE BEEN CHANGES TO PREVIOUS 
VERSIONS YOU MIGHT HAVE RECEIVED. 
THIS IS A STUDY OF THE METHOD, NOT OF THE LABORATORY. THE METHOD 
MUST BE FOLLOWED AS CLOSELY AS PRACTICABLE, AND ANY DEVIATIONS FROM 
THE METHOD AS DESCRIBED, NO MATTER HOW TRIVIAL THEY MAY SEEM, MUST 
BE NOTED ON THE REPORT FORM AND MAY LEAD TO EXCLUSION FROM THE 
EVALUATION PHASE. 
SOME OF THE HPLC CONDITIONS ARE JUST RECOMMENDATIONS WHEREAS 
OTHERS ARE BINDING. READ SECTION 7.1 CAREFULLY! DO NOT START WITH THE 
PREPARATION OF THE MATERIALS UNTIL YOU HAVE SUFFICIENT RETENTION 
AND RESOLUTION. 
SECTION 4.23 “Immunoaffinity columns” HAS NO BEARING FOR THIS TRIAL AND IS 
MEANT FOR FUTURE REFERENCE. 
BE AWARE THAT SOME MATERIALS COULD BE HIGHLY CONTAMINATED (SEE 
PROVISIONS IN SEC. 6.1 AND 8). 
 
WARNING — THE USE OF THIS PROTOCOL INVOLVES HAZARDOUS MATERIALS, 
OPERATIONS AND EQUIPMENT. THIS PROTOCOL DOES NOT PURPORT TO 
ADDRESS ALL THE SAFETY PROBLEMS ASSOCIATED WITH ITS USE. IT IS THE 
RESPONSIBILITY OF THE USER OF THIS PROTOCOL TO ESTABLISH APPROPRIATE 
SAFETY AND HEALTH PRACTICES AND DETERMINE THE APPLICABILITY OF 
REGULATORY LIMITATIONS PRIOR TO USE. 
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1. SCOPE 
This protocol specifies a candidate method for further standardisation for the determination of 
Fumonisin B1 & B2 (FB1 & FB2) in compound animal feed using liquid-chromatography with 
fluorescence detection after either pre- or post-column derivatisation. This candidate method will 
be validated for the determination of FB1 and FB2 through the analysis of naturally contaminated 
and spiked compound animal feed. 
2. PRINCIPLE 
FB1 and FB2 are extracted from the test material with a solution of 50% methanol in phosphate-
buffered saline. Then the extract is cleaned up using immunoaffinity columns (IAC). FB1 and FB2 
are eluted from the IAC using first methanol and then water. After volume adjustment the eluate is 
directly injected into the HPLC. 
3. APPARATUS 
Normal laboratory equipment and, in particular, the following: 
3.1. 250 mL flasks with screw caps 
3.2. Flask shaker 
3.3. Graduated cylinders 
5, 50, 1000, 2000 mL  
3.4. Graduated pipettes 
2 mL (Class A ± 0.01mL) 
10 mL (Class A ± 0.05mL) 
50 mL (Class A ± 0.035mL) 
3.5. Analytical balance (d= 0.01g) 
3.6. Glass micro fibre filter (e.g. Whatman 934-AH4 125 mm) 
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3.7. Filter funnel, e.g. 11 cm O.D. 
3.8. Auto sampler vials with caps 
3.9. Reservoirs for immunoaffinity columns 
20-50 mL capacity with adapter for connection to top of immunoaffinity columns. 
3.10. Volumetric flasks  
20 mL (Class A, ± 0.04 mL) 
10 mL (Class A, ± 0.04 mL) 
5 mL (Class A, ± 0.04 mL) 
2 mL (Class A, ± 0.025 mL) 
3.11. Gastight glass syringes and/or positive displacement pipettes 
Capable of precisely dispensing the following volumes: 5, 50, 125, 160, 500, and 1000µL 
3.12. Support stand for immunoaffinity columns (12 mm O.D.) 
3.13. HPLC instrumentation, comprising the following: 
3.13.1. Solvent delivery system:  
13.1.1. capable of generating a binary gradient with sufficient precision at the required 
pressures, e.g. Agilent Series 1200 pump. 
3.13.2. Auto sampler:  
13.1.2. capable of injecting sufficient volumes of injection solution with sufficient 
repeatability and, for pre-column derivatisation, capable of mixing reagent and sample 
solution before injection, e.g. Agilent Series 1200 ALS. 
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3.13.3. Chromatographic column:  
13.1.3. any column which provides symmetric peak (peak asymmetry factor 0.9< As <1.4 
at 10% of full height), sufficient retention (k > 2), and resolution (Rs >1) for FB1 & FB2, 
e.g. Agilent Zorbax SB-C18 4.6 x 150mm 3.5 µm. 
3.13.4. Fluorescence detector: 
13.1.4. capable of providing the required excitation and emission wavelengths and 
equipped with a flow cell of appropriate size, e.g. Agilent Series 1200 FLD/ Waters 474. 
3.13.5. Post-column derivatisation system (not necessary if pre-column 
derivatisation is used):  
13.1.5. either a commercial unit (e.g., Pickering Laboratories) or self-assembled. If self-
assembled the following is needed: 
3.13.5.1. Reagent pump: capable of delivering a constant pulsation-free flow of the 
derivatisation reagent against the required pressures. 
3.13.5.2. Peek tubing: of the outer diameter required by the HPLC system in use and 
varying inner diameters, e.g. 1/16"OD, 0.04", 0.02" ID, 0.01" ID, or 0.005" 
ID. 
3.13.5.3. Mixing Tee: small internal volume PEEK, e.g. VICI JR-9000-0665. 
3.14. Nylon filter 0.45 µm 
4. REAGENTS AND MATERIALS 
During the analysis, unless otherwise stated, use only reagents of recognized analytical grade. 
Solvents shall be of HPLC or better quality and only double-distilled water or water of at least 
grade 2 as defined in EN ISO 3696 shall be used. 
4.1. Double distilled or deionised water 
4.2. Methanol 
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4.3. Acetonitrile 
4.4. Potassium chloride (KCl) 
4.5. Sodium chloride (NaCl) 
4.6. Disodium hydrogenphosphate dodecahydrate (Na2HPO4*12 H2O) 
4.7. Disodium tetraborate decahydrate (Na2B4O7 *10H2O) 
4.8. Sodium carbonate (Na2CO3) 
4.9. Boric acid (H3BO3) 
4.10. Potassium sulphate (K2SO4) 
4.11. N-Acetyl-L-Cystein (NAC) 
4.12. o-Phtalaldehyde (OPA) 
4.13. β-Mercaptoethanol (BME) 
4.14. Formic Acid (98-100%) 
4.15. Phosphate buffered saline (PBS) concentrate 
Dissolve the following in 1800 ml of water (4.1):  
4 g KCl (4.4) 
160 g NaCl (4.5) 
72 g Na2HPO4*12 H2O (4.6) 
Adjust to pH 7.4 with 10 M HCl and make up to 2000 mL. 
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4.16. PBS Ready to use 
Dilute 100 ml of PBS concentrate (4.15) to 1000 ml with water. 
13.2. or  
13.3. Phosphate buffered saline (PBS) tablet: e.g. Sigma P4417 
One tablet dissolved in 200 mL of water (4.1) yields 0.01 M phosphate buffer, 0.0027 M 
potassium chloride and 0.137 M sodium chloride, pH 7.4, at 25 °C. 
4.17. Diluent 
Mix 50 parts per volume methanol (4.2) with 50 parts per volume water (4.1). 
4.18. Extraction solvent: 
13.4. Mix 50 parts per volume methanol (4.2) with 50 parts per volume of PBS (4.16). 
4.19. Reaction buffer:  
4.19.1. Post-column derivatisation: (0.006 mol/L OPA, 0.006 mol/L NAC, 0.384 mol/L 
sodium carbonate, 0.216 mol/L boric acid and 0.108 mol/L potassium sulphate). 
• Dissolve 40.7 g sodium carbonate (4.8), 13.4 g boric acid (4.9) and 18.8 g potassium 
sulphate (4.10) per 1.0 L of water (4.1). 
• Stir for 10 min. 
• Add 800 mg of OPA (4.12) per 1.0 L of the above solution. 
• Add 1 g of NAC (4.11) per 1.0 L of the above solution. 
• Stir for 10 min. 
 43 
• Sonicate for 15 min. 
• Stir for 10 min. 
• Sonicate again for 15 min. 
• Filter the solution through a 0.45 µm nylon filter (3.14). 
• Proper dissolution of the OPA is very important! 
• The reaction buffer should not be changed within a sequence of HPLC runs. 
• Prepare fresh for every sequence of HPLC runs. 
 
4.19.2. Pre-column derivatisation: (0.1 mol/L OPA, 0.24 mol/L BME, 0.08mol/L disodium 
tetraborate, 16.7% methanol (w,w,w,v)) 
• Dissolve 40 mg OPA (4.12) in 1.0 ml methanol (4.2) 
• Mix until completely dissolved 
• Add 5.0 mL of a 0.1 mol/L solution of disodium tetraborate decahydrate 
(3.8g/100mL; 4.7) 
• Mix thoroughly 
• Add 50 µL of BME (4.13) 
• Mix thoroughly 
Alternatively: 
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• Phthaldialdehyde Reagent (Sigma-Aldrich P0532) 
4.20. FB1 & FB2 stock solution 
Biopure Mycotoxin Mix 3 (Fumonisins) 
A solution of FB1 & FB2 in acetonitrile/water (1/1), concentrations see label or certificate. 
4.21. FB1 & FB2 diluted stock solution for calibration 
• Add 160 µL of the FB1 & FB2 stock solution (4.20) to a 2 mL volumetric flask 
(3.10). 
• Make up to mark (2.0 mL) with diluent (50% methanol, 4.17).  
• This will result in 2.0 mL of a 12.5 fold dilution of 4.20 in 
methanol/acetonitrile/water (46/4/50, v/v/v), respectively. 
• Prepare this diluted stock solution twice! 
4.22. Calibration solutions 
From each of the two diluted stock solutions (4.21) prepare five levels of calibration 
solutions by adding the volumes of diluted stock solution listed in the following table to a 
volumetric flask (3.10) of the indicated volume and make up to the mark with diluent 
(4.17).  
Calculate the concentrations of FB1 & FB2 for the different calibration levels by dividing 
the stated concentrations of the stock solution (4.20) by the final dilution stated above. 
Should you observe saturation of the detector signal at the highest calibration level dilute 
250 µL of diluted stock solution into 2.0 mL for a final dilution of 100. 
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Calibrant Diluted stock 
solution (4.21) 
[µL] 
Volumetric flask 
(3.10) 
[mL] 
Final dilution of stock 
solution (4.20) 
1 50 20.0 5000 
2 125 10.0 1000 
3 125 5.0 500 
4 500 2.0 50 
5 1000 2.0 25 
4.23. Immunoaffinity columns  
13.5. The immunoaffinity columns must contain a stationary phase with immobilized 
monoclonal antibodies specific to, at least, Fumonisin B1 and B2.  To be suitable for this 
method they must meet the requirements stated below: 
An aliquot of an extract of a blank compound animal feed material is spiked with FB1 & 
FB2 at either 920 (high) or 110 (low) ng/mL for the sum of both. Then dilute 5.0 mL of 
that spiked extract to a total volume of 50.0 mL (see Sec 6.1). 
Following the procedures described in Sec 6.2 and 6.3 this will result in expected 
concentrations in the injection solutions of either 460 or 55 ng/mL for the sum of FB1 & 
FB2. 
After measuring (Sec. 7) these solutions the observed concentrations of FB1 & FB2 can be 
calculated with Equ. I and II of Sec. 8. Dividing the sum of the observed concentrations 
of FB1 & FB2 by the expected concentrations will result in the yield of the 
immunoaffinity columns. 
These yields must be 99%±18% (U, k=2) at the high level and 118%±18% (U, k=2) 
at the low level. 
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The above column test should be performed for each level on at least three randomly 
selected columns of every new lot of immunoaffinity columns which will be used. Should 
the tested lot not meet the above requirements either a new lot which does should be 
obtained or the conditions described in Sec. 6.2 need to be adjusted such that the 
requirements are met (the user instructions supplied with the columns are a good starting 
point). 
!!!Any changes to the clean-up procedures will necessitate a revalidation of the 
clean-up and all subsequent steps (chromatography)!!! 
4.24. Test materials 
Homogenized, ready-to-be-extracted, and coded; to be prepared once each. 
4.25. Spiking material 
Homogenized, ready-to-be-extracted material for recovery determination; to be prepared 
once each. 
4.26. Spiking solutions 
FB1 & FB2 in a solution of acetonitrile/ water (1/1, v/v). 
5. SPIKING PROCEDURE 
To 20.0 g of spiking material (4.25) add a defined volume of a spiking solution (4.26). Let stand 
for 30 min before proceeding with the sample preparation (Sec. 6). Find details in the Spiking 
Protocol included with the documentation. 
6. SAMPLE PREPARATION 
6.1. Extraction of FB1 & FB2 
• Weigh 20.0 g, to the nearest 0.1 g, of the test sample into a large enough container with 
lid, e.g. 250 mL flask (3.1). 
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• Add 200.0 mL of extraction solvent (4.18), cap, and shake vigorously by hand, so that the 
material disperses evenly. 
• Put on a shaker (3.2) for 120 min. Choose speed such that the material is mixed well 
without collecting in the top of the flask. 
• Allow the extracted sample to settle after shaking. 
• Of the supernatant take 5.0 mL and dilute with PBS (4.16) to a total volume of 50.0 mL 
and mix. 
• Prepare a filter funnel (3.7) with a glass micro fibre filter (3.6). 
• Filter the diluted supernatant of the extracted sample into a new flask (3.1). 
• The diluted filtered extract may be stored at 4 to 10 ºC overnight. 
• In case of a highly contaminated material above 10000 µg/kg (see Sec. 8) take 10.0 
mL of the stored filtered diluted extract and dilute again with PBS (4.16) to a total 
volume of 50.0 mL and mix. 
6.2. Clean up 
• Take one immunoaffinity column (IAC, 4.23) per extract. 
• Attach a reservoir (3.9), do not empty storage solution from column. 
• To the reservoir add 25.0 mL of the filtered diluted extract (6.1). 
• Open the column outlet. 
• Allow everything to pass slowly through the column. Flow rate should be about one drop 
per second. 
• After the extract has passed completely, wash the IAC with 10 mL of PBS (4.16). 
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• Pass air through the IAC (e.g., using a properly fitted large syringe) in order to expel 
excess PBS. 
• Place a 5 mL volumetric flask (3.10) or a 5 mL graduated cylinder (3.3) underneath the 
IAC and add 5 x 500 µL of methanol (4.2) to the IAC (add next aliquot only after 
previous has completely passed). 
• Collect the eluate in the volumetric flask (3.10) or graduated cylinder (3.3). 
• Add 2.0 mL of water (4.1) after all of the methanol (4.2) has passed through the column. 
• Continue to collect the eluate in the same volumetric flask or graduated cylinder. 
• Carefully pass air through the column in order to collect most of the applied water (4.1). 
6.3. Test solution 
• For pre-column derivatisation: Make up the content of the volumetric flask or 
graduated cylinder to the 5 mL mark with water (4.1). 
• For post-column derivatisation: add 5uL of formic acid (4.14) and make up the content 
of the volumetric flask or graduated cylinder to the 5 mL mark with water (4.1). 
• Mix the content of the volumetric flask or graduated cylinder and transfer an aliquot to an 
autosampler vial (3.8). 
• This test solution may be stored at 4 to 10 ºC for up to two days. 
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7. MEASUREMENTS: 
7.1. HPLC operating conditions 
Below we provide recommendations for the operating conditions. More likely than 
not you will have to adjust injection volumes, the percentage of organic modifier in 
isocratic or gradient mode, the flow rate, and/or the column temperature to obtain 
appropriate resolution and retention (3.13.3) for your equipment. 
DO NOT USE A MOBILE PHASE ADDITIVE OTHER THAN FORMIC ACID IN THE INDICATED 
CONCENTRATIONS!  
To facilitate any necessary optimization work an additional container with a blank 
material which does not contain detectable amounts of FB1 & FB2 and a spare 
immunoaffinity column is included. Prepared acc. to Sec. 6 the resulting injection 
solution may be used for a few days. Compare the blank injection solution to an 
aliquot which has been spiked with a standard to identify possibly co-eluting matrix 
related peaks. Try to obtain sufficient peak resolution. That is especially relevant for 
pre-column derivatisation! 
7.1.1. Pre-column derivatisation 
Using the equipment outlined in 3.13, the following conditions have shown to produce 
satisfying results: 
Auto sampler injector program: 
• Aspire 20 µL pre-column reaction buffer (4.19.2) 
• Aspire 40 µL test solution (6.3) 
• Aspire 20 µL pre-column reaction buffer (4.19.2) 
• Mix 20 times 
• Inject all 
The above can be done manually (adjusting the total volume while maintaining the 
relative volumes if necessary) if it is ascertained that the solution is injected within 3 
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min after mixing. It is also important that the time period between mixing and injecting 
is the same for all test and calibration solutions. 
Injection volume: 80 μL  
Column temperature: 40°C 
Flow : 1.0 mL/ min 
Fluorescence detector: Excitation λ: 335 nm; Emission λ: 440 nm (it should be 
checked if these are local maxima for the fluorescence detector in use!) 
Mobile phase: A: 0.5% formic acid (4.14) in water (4.1) 
B: 0.5% formic acid (4.14) in methanol (4.2) 
(do not use any other additive than formic acid!) 
Gradient settings (HPLC dwell volume 0.8 mL): 
Time [min] B [%] 
0 69.5 
14 79 
14.01 100 
17.01 100 
17.02 69.5 
20 69.5 
Instruments with different dwell volume will need adjustment of the gradient to achieve 
the same separation as shown in Appendix A. The aim should be an apparent capacity 
factor at elution for FB1 of k > 3. 
7.1.2. Post-column derivatisation 
Instructions for self-assembled system: 
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The flow path to the chromatographic column (3.13.3) is unchanged from normal 
operation. The outlet of the column is connected to one of the outside ports of a 
mixing Tee (3.13.5.3). The tubing from column to mixing Tee should be as short as 
possible. 
The other outside port of the mixing Tee is connected to the outlet of a pump 
(3.13.5.1) delivering the reagent flow. This connection should be made of a long 
piece of 0.005" ID PEEK tubing (3.13.5.2) so that a sufficient back pressure is 
created for the reagent pump to work properly. It is of utmost importance that the 
reagent flow is delivered pulsation-free. A slight pulsation can be minimized be 
introducing a large damping volume between the pump and the back pressure 
creating PEEK tubing. Large ID PEEK tubing can serve this purpose. 
The remaining centre port of the mixing Tee is connected through a reagent loop to 
the fluorescence detector. The length, and therefore the volume, of this reagent loop 
is a balance between retaining the resolution of the chromatographic column (short) 
and achieving complete reaction (long). The internal diameter is of lesser 
importance. If chosen too small excessive back pressure will be created. Satisfying 
results were achieved with a 2.5m length of 0.02" ID PEEK tubing. 
Using the equipment outlined in 3.13, the following conditions have shown to produce 
satisfying results: 
Injection volume: 50 μL  
Column temperature: 45°C 
Flow : 1.2 mL/ min (mobile phase); 0.45 mL/min (post-column reagent (4.19.1)) 
Fluorescence detector: Excitation λ: 335 nm; Emission λ: 440 nm (it should be 
checked if these are local maxima for the fluorescence detector in use!) 
Mobile phase: A: 0.1% formic acid (4.14) in water (4.1) 
B: 0.1% formic acid (4.14) in acetonitrile (4.3) 
(do not use any other additive than formic acid!) 
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Gradient settings: 
Time [min] B [%] 
0 34 
13 34 
13.01 95 
16 95 
16.01 34 
19 34 
This separation is isocratic but to avoid accumulation of matrix compo–nents a step up 
to 95% B is included. The percentage of organic modifier should be adjusted such that 
the capacity factor for FB1 will be k > 2. 
7.2. Determination of fumonisins in test solutions 
Inject aliquots of the test solutions (6.3) into the chromatograph using the same 
conditions as used for the calibration solutions (4.22). 
7.3. Batch (Sequence) composition 
Each of the included test materials (4.24) and spiking materials (4.25) are to be prepared 
once. For each batch of runs all the calibration solutions (4.22) are to be run at the 
beginning and at the end of the batch. At the beginning of each batch run the five levels 
of calibrants prepared from the first diluted stock solution (4.21) from lowest to highest 
concentration followed by the five levels from the second diluted stock solution from 
highest to lowest. Then run the test solutions (6.3) once. Repeat the runs of the test 
solutions in reversed order for a second injection. At the end of the batch repeat the 
calibration solutions in reversed order from the beginning. Therefore, a batch of runs 
would, for example, look like Table 1 below. 
7.4. Calibration 
Plot the signals (peak area or height) of all the measured calibration solutions against the 
corresponding concentrations for FB1 and, separately, for FB2. Do not use means of the 
multiple injections! With linear regression estimate slope and intercept of each of the two 
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calibration functions (FB1 & FB2). Check for significance of the intercept and for 
linearity (use e.g. a residuals vs. fitted-values plot). 
7.5. Peak identification 
Identify the Fumonisin B1 & B2 peaks in the test solution by comparing the retention 
times with those of the calibration solutions. The signal (peak area or height) of FB1 or 
FB2 in the test solution must fall within the calibration range. If the FB1 and/or FB2 signal 
in the test solution exceeds the signals of the highest calibration solution the test solution 
shall be diluted with diluent (4.17) to bring it within calibration range, and be reanalysed. 
The dilution factor must be incorporated into all subsequent calculations. 
Run Identity Run Identity Run Identity
1 Cal A level 1 12 Material B 23 Cal B level 1
2 Cal A level 2 13 Material C 24 Cal B level 2
3 Cal A level 3 14 Material D 25 Cal B level 3
4 Cal A level 4 15 Material E 26 Cal B level 4
5 Cal A level 5 16 Material F 27 Cal B level 5
6 Cal B level 5 17 Material F 28 Cal A level 5
7 Cal B level 4 18 Material E 29 Cal A level 4
8 Cal B level 3 19 Material D 30 Cal A level 3
9 Cal B level 2 20 Material C 31 Cal A level 2
10 Cal B level 1 21 Material B 32 Cal A level 1
11 Material A 22 Material A
Table 1: Example for the order of runs in a batch of runs 
8. DETERMINATION OF CONCENTRATIONS 
Using the estimated slopes and intercepts (if significant, otherwise use zero) from linear regression 
(7.4) calculate the concentrations of FB1 (cT(FB1)) and FB2 (cT(FB2)) in the test solutions (6.3) from 
the mean signal of the two injections as follows: 
1
11
)1( slope
interceptsignal
FB
FBFB
FBTc
−= [ng/mL] (I) 
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2
22
)2( slope
interceptsignal
FB
FBFB
FBTc
−= [ng/mL] (II) 
If the test solution was diluted because of a signal above the calibration range (7.5) multiply 
the calculated concentrations of FB1 (cT(FB1)) and FB2 (cT(FB2)) with the dilution factor. 
To calculate the mass fractions (cSMP) of the analytes in the original materials use the following 
equation: 
SMP
T
SMP mVV
VVVcc ××
×××=
24
135  [ng/g or µg/kg] (III) 
with 
cT = calculated concentration of either FB1 (I) or FB2 (II), possibly corrected for dilution. 
mSMP = weight of the test material used for extraction (20.0 g). 
V1 = total volume of the extraction solvent (200.0 mL). 
V2 = volume of the aliquot of the filtered raw extract used for dilution (5.0 mL). 
V3 = total volume of the diluted filtered raw extract (50.0 mL). 
V4 = volume of the aliquot of the diluted filtered raw extract applied to the IAC (25.0 mL). 
V5 = total volume of the test solution (5.0 mL). 
If the weight of the test material and the volumes described herein before are kept the above 
equation (III) can be simplified to: 
20×= TSMP cc  [µg/kg] (IV) 
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Should the result of equation IV be larger than 10000 µg/kg or if it is known before hand that the 
contamination level might exceed that value clean-up the respective diluted filtered extract (see 
Sec. 6.1) using an additional dilution (additional dilution factor 50/10 = 5). The simplified 
equation will then be:  
100520 ×=××= TTSMP ccc  [µg/kg] (V) 
Carry out the above calculations for FB1 and FB2. 
 56 
9. Appendix A: 
9.1. Example chromatogram with post-column derivatisation and the conditions described herein 
before. 
min0 2 4 6 8 10 12 14 16
LU    
5
10
15
20
25
30
35
 FLD1 A, Ex=335, Em=440 (FUM\2008\20080625\2008062501 2008-06-25 08-48-24\1CI-5001.D)
FB1
FB2
 
Animal feed blank material spiked at a level of ca. 5 mg/kg for the sum of FB1 & FB2. IAC eluate was dried down and 
reconstituted with 0.5 mL mobile phase. 
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9.2. Example chromatograms with pre-column derivatisation and the conditions described herein 
before. 
min0 2 4 6 8 10 12 14 16
LU    
0
5
10
15
20
25
 FLD1 A, Ex=335, Em=440 (FUM\2008\20080623\2008062302 2008-06-23 17-29-38\1CI-4901.D)
FB2
FB1
 
Animal feed blank material spiked at a level of ca. 5 mg/kg for the sum of FB1 & FB2. IAC eluate was dried down and 
reconstituted with 0.5 mL mobile phase. 
min0 2 4 6 8 10 12 14 16
LU    
0
1
2
3
4
5
 FLD1 A, Ex=335, Em=440 (FUM\2008\20080723\FUM-2008072301 2008-07-23 15-10-18\1BG-1601.D)
FB1
FB2
 
Animal feed material naturally contaminated at a level of ca. 6 mg/kg for the sum of FB1 & FB2. IAC eluate was not 
dried down. 
 
 58 
Cover letter: 
 
EUROPEAN COMMISSION 
JOINT RESEARCH CENTRE 
 
Institute for Reference Materials and Measurements  
Food safety and quality 
 
Geel, 26 September 2008 
D08/FSQ/ABR/bk/D (2008) 24453 
 
 
Dear participant, 
I would like to welcome you to a collaborative study to validate a method for the determination of the 
sum of Fumonisin B1 & B2 in compound animal feed. With this letter you will have received the 
materials and documentation necessary to carry out the analyses. 
In order to make this retrial a success it is of utmost importance that you read the included 
documentation carefully. The protocol has changed from previous versions you might have received 
(see Foreword).  
Please fill out the material receipt form and send it back to us. The materials you received have to be 
refrigerated until analysis. The analysis should only be started once you are certain that all the needed 
equipment (Protocol Sec. 3) and reagents (Protocol Sec. 4) are available. Also use the included blank 
material and one spare IAC column to prepare a blank injection solution with which the gradient 
settings can be optimized for your HPLC (Protocol Sec. 7). You have eight weeks until early 
December for reporting which should be sufficient time. 
Prepare each of the ten materials once and determine their fumonisin concentrations as described in the 
protocol. Then fill out the report form and, preferably, email it to us. Keep all the data concerning this 
trial at hand in case we need to come back to you for clarification. 
Once you have carried out all the analyses, please, also fill out the questionnaire and email it back to 
us. Receiving the electronic versions of those forms will facilitate our work very much. 
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Should you have comments or questions, please, do not hesitate to contact us at jrc-irmm-crl-
mycotox@ec.europa.eu  
The deadline for reporting is 01 Dec 2008. 
 
 
Thanking you for your participation we remain 
With kind regards 
 
Andreas Breidbach 
Contact: 
Andreas Breidbach, Telephone:+32-(0)14-571 205, andreas.breidbach@ec.europa.eu 
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SPIKING PROTOCOL 
 
 
This box contains two containers labelled "Spike A" and "Spike B". These are materials to be used for 
recovery determinations. 
 
There are also two amber ampoules labelled "Spike A" and "Spike B". These are solutions of FB1 & 
FB2 in acetonitrile/ water (50/50, v/v). 
 
To determine the recovery of the method proceed as follows (the references in parentheses refer to the 
method protocol): 
 
• Weigh 20.0 g, to the nearest 0.1 g, of the test sample into a large enough flask with lid, f.i. 250 
mL flask (3.1). 
• Carefully tap the amber ampoules on the bench so as to collect all liquid at the bottom of the 
ampoule. 
• Wrap ampoule in some heavy tissue and wearing sturdy gloves carefully break off the top of 
the ampoule at the mark (glass surface pre-scored). 
• Add the volume of spiking solution indicated in the table below to the test sample in the flask.  
 
Material Solution Volume  
Spike A Spike A 600 µL 
Spike B Spike B 500 µL 
 
• Apply the solution such that it is distributed over a wide area of the sample material. Do not 
apply to the walls of the flask. After one minute gently shake the flask to further distribute the 
application area (only side-to-side motion, not up-down). 
• Let stand for 30 min at room temperature to allow the acetonitrile to evaporate. 
• Shake to distribute the contaminated material evenly and tap flask on bench to collect all 
material at the bottom of the flask. 
• Proceed with the addition of 200.0 mL of extraction solvent (4.18) in section 6.1 Extraction of 
FB1 & FB2 in the method protocol. 
Fumonisin Method Validation Study 2008
Questionnaire
Please read this questionnaire before you start the analysis and complete it after you 
have carried out the analysis. 
Analyst:
Laboratory:
1 Did your laboratory already perform Fumonisin analysis prior to this study?
Yes (go to 2) No (go to 3)
2 If you did, please, briefly describe the methodology used in the fields below.
Extraction 
solvent: Separation:
Clean-up: Detection:
For how long have you been performing Fumonisin analysis?
< 3 months        3 - 12 months        > 12 months
3 If you did not, describe which parts of the proposed method were unfamiliar to you in the field below?
4 Was the description of the method adequate?
Yes (go to 6) No (go to 5)
5 What could be improved about the method description?
6 Did you at any step deviate from the method protocol sections 4, 5, or 6?
Yes (go to 7) No (go to 8)
7 If you did, please state where and why in the field below.
8 Approximately, how long did the clean-up step (6.2. of the method protocol) for an individual sample take on average?
< 20 min 20 - 40 min > 40 min
9 Please describe the HPLC instrument used in the fields below.
Pump: Detector:
ALS: Column:
10 Did you use pre- or post-column derivatization? Please describe set-up briefly in the field below.
Pre Post
11 Did you deviate from method protocol section 7 (Measurements)?
Yes (go to 12) No (go to 13)
12 If you did, please state where and why in the field below.
13 Did you use peak area or peak height for evaluation?
Peak area Peak height
Thank you for completing this questionnaire!
Once you filled-in this form save it! To facilitate our work we ask you to submit the electronic 
version by using the "Submit by Email" button. Should that not work use the "Print Form" 
button  and fax or mail it to:
JRC-IRMM
A. Breidbach
Retieseweg 111
B-2440 Geel
Belgium
Fax: ++32 14 571 783.
Print FormSubmit by Email
EUROPEAN COMMISSION 
JOINT RESEARCH CENTRE 
Institute for Reference Materials and Measurements  
Food safety and quality
MATERIALS RECEIPT FORM
Name and Institution: 
NOTE: UPON RECEIPT STORE ALL MATERIALS 
IN A REFRIGERATOR AT 4 °C!
Please ensure that the items listed below have been received undamaged, and then 
check the relevant statement: 
Date of the receipt 
Items are missing/damaged. I require a replacement. Yes        No 
Specify here what you want replaced: 
Contents of parcel 
a) Six test material containers identified by a code 
b) Two test material containers identified as “Spike A” 
c) Two test material containers identified as “Spike B” 
d) Two amber ampoules identified as “Spike solution A” 
e) Two amber ampoules identified as “Spike solution B” 
f) One test material container identified as “Animal feed blank” 
g) 14 immunoaffinity columns 
h) Vial with Fumonisin Mix reference material (if it was requested) 
i) Documentation: Method protocol, Spiking protocol, Cover letter, Copy of Certificate of 
Fumonisin Mix reference material (if it was requested), Results form, 
Questionnaire form, this form 
Please fax or email the completed form to: 
Dr. Andreas Breidbach 
European Commission - Joint Research Centre 
Institute for Reference Materials and Measurements 
B-2440 Geel, Belgium 
Fax No: 0032-14-571 783 
Print FormSubmit by Email
Fumonisin Method Validation Study 2008
Results
Analyst:
Laboratory:
Instructions:
Please enter in the provided fields sample codes and corresponding 
concentrations for FB1 & FB2 as calculated using Eq. III, IV, or V of section 8 
of the method protocol. Enter the concentrations in µg/kg rounded to full 
unit, e.g. 1181.4 as 1181! 
Once you filled-in the form save it! To facilitate our work we ask you to use 
the "Submit by Email" button to email to us the electronic version. Should 
this not work use the "Print Form" button to print it and fax or mail it to: JRC-
IRMM, A. Breidbach, Retieseweg 111, B-2440 Geel, Belgium; Fax: ++32 14 
571 783
Sample code Concentration
FB1 FB2
Spike A 1 µg/kg µg/kg
Spike A 2 µg/kg µg/kg
Spike B 1 µg/kg µg/kg
Spike B 2 µg/kg µg/kg
µg/kg µg/kg
µg/kg µg/kg
µg/kg µg/kg
µg/kg µg/kg
µg/kg µg/kg
µg/kg µg/kg
Print FormSubmit by Email
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Abstract 
A collaborative study to validate a method to determine the sum of Fumonisin B1 (FB1) and B2 (FB2) in 
compound animal feed and maize by immunoaffinity column clean-up and High Performance Liquid 
Chromatography with Fluorometric Detection (HPLC-FLD) was conducted by the Joint Research Centre – 
Institute for Reference Materials and Measurements with the participation of 16 laboratories of 12 Member 
States of the European Union. 
  The method consisted of extraction of the Fumonisins from the sample with 50 % methanol in phosphate-
buffered saline, clean-up with immunoaffinity columns, and detection of the o-phtaldialdehyde derivatives after 
either pre- or post-column derivatisation with HPLC-FLD. 
  Five materials, consisting of compound animal feed and maize, were tested.  Three of the materials were 
naturally contaminated, and two were naturally contaminated and additionally spiked.  The contamination levels 
ranged from 3 to 16 mg/kg for the sum mass fraction of FB1 and FB2.   
  Four laboratories had to be excluded from the evaluation because of non-compliance.  For the remaining 12 
laboratories repeatability and reproducibility were computed using robust statistical methods.  Relative 
repeatability and reproducibility standard deviations of 2.0 to 5.3 %, and 15 to 20%, respectively, were found.  
Horwitz ratios ranged from 1.2 to 1.9 and were all acceptable. 
  We deem the method as fit for the purpose of enforcing recommended maximum levels of the sum of 
Fumonisin B1 and B2 in animal compound feed, and maize intended for animal feed, and have submitted it to 
the European Committee for Standardisation (CEN)/ Technical Committee (TC) 327 Animal feeding stuffs. 
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